SYNVISC ONE (HYLAN G-F 20) INJECTION
Report
- Report Number
- 2246315-2011-00291
- Event Type
- Other
- Date Received
- November 22, 2011
- Date of Event
- October 1, 2011
- Report Date
- November 15, 2011
- Manufacturer
- GENZYME BIOSURGERY (RIDGEFIELD)
- Product Code
- MOZ
- PMA / PMN Number
- P940015
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- US
- Reporter Occupation
- OTHER
- Health Professional
- N
Narratives
MANUFACTURER'S COMMENT: THE BENEFIT-RISK RELATIONSHIP OF THE PRODUCT IS NOT AFFECTED BY THIS REPORT.
CASE DESCRIPTION: SPONTANEOUS REPORT WAS RECEIVED ON (B)(6) 2011 FROM A (B)(6) YEAR OLD FEMALE PATIENT, INITIALS (B)(6) WITH OSTEOARTHRITIS. THE PATIENT'S MEDICAL HISTORY INCLUDED PHLEBITIS. ON (B)(6) 2011, THE PATIENT INITIATED SYNVISC-ONE (HYLAN G-F 20) 6 ML INJECTION ONCE IN THE LEFT KNEE. THE PRODUCT LOT NUMBER WAS NOT REPORTED. ONE WEEK AFTER RECEIVING THE INJECTION, SHE BEGAN EXPERIENCING INCREASED SWELLING, PAIN, DIFFICULTY IN WALKING AND CALF PAIN. THE X RAY OF THE LEFT KNEE AND DOPPLER OF THE CALF WERE PERFORMED ON THE ADVICE OF HER FAMILY PRACTITIONER, AS THE PATIENT HAD A HISTORY OF PHLEBITIS. THE RESULTS WERE NEGATIVE. SHE HAD BEEN ON BEDREST, USING ICE AND HEAT. SHE COULD NOT BEND THE KNEES ALSO. ON (B)(6) 2011, SHE VISITED HER ORTHOPEDIC HEALTH CARE PROFESSIONAL AND APPROXIMATELY 50 CC OF THE FLUID WAS DRAINED FROM THE KNEE AND SHE WAS GIVEN AN INJECTION OF DEPO MEDROL (METHYLPREDNISOLONE ACETATE). ALL LABS PERFORMED ON THE FLUID WERE NEGATIVE. BY (B)(6) 2011, HER KNEE ALMOST RETURNED TO NORMAL. NO ACTION WAS TAKEN WITH SYNVISC-ONE. THE OUTCOME OF THE EVENT OF CALF PAIN AND DIFFICULTY WALKING WAS NOT PROVIDED. CONCOMITANT MEDICATIONS WERE NOT PROVIDED. THE INTENSITY FOR ALL THE EVENTS WAS NOT PROVIDED.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1 | SYNVISC ONE (HYLAN G-F 20) INJECTION | INTRA-ARTICULAR HYALURONIC ACID | MOZ | GENZYME BIOSURGERY (RIDGEFIELD) | UNK | UNK |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 69 YR | Required Intervention |